Equities

China Wah Yan Healthcare Ltd

China Wah Yan Healthcare Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)0.38
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 17 2017.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

China Wah Yan Healthcare Ltd is an investment holding company principally engaged in the medical and healthcare businesses. The Company operates through three segments. The Medical and Well-being segment is engaged in the operation of medical centres specialising in the diagnosis and treatment of tumour. The Segment is also engaged in the operation of optical products and eye-care services retail shops. The Segment is also engaged in the manufacturing and sale of pharmaceutical and health related products. In addition, the Segment is engaged in the provision of medical laboratory testing services, health check services and obstetric and gynaecological services. The Health Management segment is engaged in the operation of sports and healthcare clubhouses. The Asset Management segment is engaged in the investment in financial assets, fixed assets and distressed assets, as well as loan financing.

  • Revenue in HKD (TTM)193.87m
  • Net income in HKD-133.72m
  • Incorporated1989
  • Employees120.00
  • Location
    China Wah Yan Healthcare Ltd36th Floor, Times Tower391-407 Jaffe RoadWanchai Hong KongHKG
  • Phone+852 21873085
  • Fax+852 21873570
  • Websitehttp://www.chinawahyan.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CA Cultural Technology Group Ltd453.14m-375.05m82.74m353.00--0.0983--0.1826-0.3511-0.35110.43780.7120.2237330.162.16---18.96-1.35-27.43-1.8913.9924.65-84.75-4.451.06-0.93290.4648---5.26-10.08-551.40------
China Wah Yan Healthcare Ltd193.87m-133.72m123.90m120.00------0.6391-0.4101-0.41010.59460.44380.2759.2313.57---18.97-23.88-36.31-42.2330.9739.12-68.98-139.860.8045-0.50790.7149---0.17827.6057.06------
China Digital Culture (Group) Ltd62.67m-45.75m157.69m63.00------2.52-0.0186-0.01860.0249-0.02240.13351.191.64---9.75-17.03-25.27-20.5643.4638.39-73.00-96.990.1255-0.26631.17--11.19-21.2087.31------
Niraku GC Holdings Inc1.31bn-69.78m271.97m1.63k--0.23451.540.2073-0.0584-0.05841.100.96990.3047562.43321.87805,068.60-1.63-1.99-2.14-2.4617.7016.73-5.34-5.211.081.480.69--19.78-5.3178.45--8.5225.52
Data as of Nov 17 2017. Currency figures normalised to China Wah Yan Healthcare Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Meeschaert Asset Management SAas of 04 Aug 202260.000.00%
Data from 04 Aug 2022 - 04 Aug 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.